Tyler J Curiel

26PUBLICATIONS
182CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Receptors and membrane biologyCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Mar 25, 2026
Telmisartan increases olaparib efficacy in homologous recombination proficient tumors by augmenting type I interferon production.

Clare E Murray, Carlos O Ontiveros, Jordan Wentworth

|Nov 19, 2025
Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling.

Carlos O Ontiveros, Myrna G Garcia, Clare E Murray

|Nov 14, 2025
The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity.

Eleni Chantzoura, Efrat Altman-Sharoni, Xavier Michelet

|Oct 08, 2025
Ligand-receptor interactions induce and mediate regulatory functions of BATF3+ B cells.

Hui Yan, Rui Wang, Suryavathi Viswanadhapalli

|Jul 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.

Dhan Chand, David A Savitsky, Shanmugarajan Krishnan

|Sep 28, 2023
Considerations and Approaches for Cancer Immunotherapy in the Aging Host.

Carlos O Ontiveros, Clare E Murray, Grace Crossland

Pageof 5

Frequent Collaborators

8 joint publications

Ryan Michael Reyes

5 joint publications

Jose R Conejo-Garcia

3 joint publications

Harshita Gupta

3 joint publications

Bogang Wu